ANAPTYSBIO, INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Anaptysbio, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q4 2024.
  • Anaptysbio, Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $8.18M, a 0.9% increase year-over-year.
  • Anaptysbio, Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $34M, a 2.54% increase year-over-year.
  • Anaptysbio, Inc annual Share-based Payment Arrangement, Expense for 2024 was $34M, a 2.54% increase from 2023.
  • Anaptysbio, Inc annual Share-based Payment Arrangement, Expense for 2023 was $33.2M, a 21.4% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $34M $8.18M +$73K +0.9% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $34M $8.19M +$382K +4.89% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $33.6M $7.54M -$883K -10.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $34.5M $10.1M +$1.27M +14.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $33.2M $8.11M +$1.43M +21.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $31.8M $7.81M +$1.54M +24.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $30.2M $8.43M +$1.77M +26.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $28.5M $8.86M +$1.12M +14.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $27.4M $6.69M Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $6.27M +$1.91M +43.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $6.66M +$2.97M +80.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $7.74M +$4.43M +134% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $4.36M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $3.69M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $3.32M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.